Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.
about
Crystal Structure of Human Cytochrome P450 2D6 with Prinomastat BoundPharmacokinetics and metabolism of thioridazine during co-administration of tricyclic antidepressants.Polymorphism in the metabolism of drugs, including antidepressant drugs: comments on phenotypingInhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidineThe effects of beta-adrenoceptor antagonists and levomepromazine on the metabolic ratio of debrisoquine.Inhibitory effects of neuroleptics on debrisoquine oxidation in manSparteine oxidation is practically abolished in quinidine-treated patients.Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity.Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions.The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomesOxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase).Effect of quinidine on the dextromethorphan O-demethylase activity of microsomal fractions from human liver.Influence of amesergide treatment on the dextromethorphan test.Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype.Metabolism of thioridazine by microsomal monooxygenases: relative roles of P450 and flavin-containing monooxygenase.Quinine is a more potent inhibitor than quinidine in rat of the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase.Why is quinidine an inhibitor of cytochrome P450 2D6? The role of key active-site residues in quinidine binding.The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol.
P2860
Q27677093-F6CA8ECC-3A0E-44A6-AAB2-7095A644A97EQ33181081-25A107F2-5FDB-459A-9EA0-11961F20EE3CQ33921325-B1AB38EF-D181-4B94-B934-B8B4E31E414AQ34346469-64F33FD9-0DC2-4A1F-BE80-3A3DAB14EA3FQ34357697-3A657E8C-541F-40AB-85A8-08E568496040Q34447792-317DED5C-B480-43B4-982F-0465D39DECBAQ34447888-4EDC51D9-BA28-4AA8-9305-BF86B271B25BQ34909452-DA6D8F71-40E0-43ED-87B6-2CD9C6562E24Q36497020-BF38D209-5FB3-495C-8B6D-2C0386B6D58EQ42052107-BBADCAE3-0643-447F-9274-D6454194D469Q42174751-A027BDF5-4692-4F48-B01F-6DD195AE8231Q42229235-FEA88E4E-3215-4283-8994-CC1A2C483B64Q43201703-9055D5B9-A38F-4C97-887A-1438BF157BA2Q44395024-EE5A5A07-290E-484B-A5E2-EC8A1C2CE300Q44862826-1DB646AE-74FA-409A-993E-5462285FD7D2Q44871609-C1184BD8-F23C-49CF-A564-8E61A43DCC44Q46703082-8123959D-FC0D-480C-ABA4-5D8657178111Q46970949-72CDFBE5-8E4D-4BDF-807A-B32A19B0A4BF
P2860
Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.
@en
Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.
@nl
type
label
Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.
@en
Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.
@nl
prefLabel
Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.
@en
Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.
@nl
P2093
P1476
Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.
@en
P2093
Birgersson C
Ericsson O
Göransson M
Henthorn T
Sjöqvist F
von Bahr C
P304
P356
10.1016/0006-2952(85)90533-7
P407
P577
1985-07-01T00:00:00Z